https://www.inspiredhygiene.com/feed&follow=1
-
STAT+: Pharmalittle: Biogen sells stake in biosimilars business for $2.3 billion; Lilly gives up on a lucrative idea
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on the eve of a winter storm in our part of the world that could either...
-
Opinion: Break the stranglehold of the doctor-patient visit on health care innovation
The electric engine, invented in 1834 , was touted as the productivity booster that would revolutionize manufacturing. Yet it took three decades...
-
Opinion: Maximizing kidney transplant equity means minimizing geography
For decades, geography heavily influenced who received kidney and other organ transplants in the United States and who didn’t. An...
-
‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
The FDA announced this week that it is limiting use of two monoclonal antibody drugs for Covid that do not work against the Omicron variant...
-
In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog
Back in the pandemic’s first wave, Michelle Monje was worried about Covid-19’s power to muddle the brain. Seeing the massive...
-
STAT+: ‘Nowhere to hide’: As biotech stocks plummet, an industry is being reshaped by the fallout
Biotech investors, once the envy of Wall Street, have slipped into despondency. After a double-digit decline in 2021, the sector has fallen...
-
STAT+: Biogen sells stake in Samsung venture for $2.3 billion
Biogen is selling its stake in a pharmaceutical joint venture with the South Korean conglomerate Samsung for $2.3 billion, the company said...
-
STAT+: U.S. International Trade Commission will investigate AbbVie claims that rival stole secrets
The U.S. International Trade Commission agreed to investigate whether two companies misappropriated trade secrets in connection with plans to...
-
Listen: Janet Woodcock on Covid antibodies, vaccines for kids, and responding to Omicron
Who gets to be an “expert” on Covid-19? Are Americans entitled to drugs that don’t work? And how does the FDA deal with...
-
Some Americans are hesitant about Covid vaccines. But they’re all-in on unproven treatments
Gov. Ron DeSantis of Florida has refused to say whether he’s received a booster shot. He’s suggested, misleadingly, that Covid-19...
-
Uber Health’s new chief medical officer wants to sharpen its message
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
STAT+: Pharmalittle: Biden administration used hospital funds to buy Covid vaccines and drugs; a cancer drug may help combat HIV
Good morning, everyone, and how are you today? There is a decidedly wintry feel to the sparkling sun and clear blue skies that are greeting us....
-
Opinion: Doctors were complicit in Holocaust atrocities. Current and future health care workers need to know that
The liberation of the concentration camp at Auschwitz on Jan. 27, 1945, revealed many horrors. Among them were the atrocities perpetrated by...
-
STAT+: Fecal matter transplants could help certain cancer drugs work in more people, study shows
Checkpoint inhibitors like Keytruda and Opdivo can be incredibly powerful cancer-killing drugs — when they work, that is, which is less...
-
STAT+: The Pajama Interview: A conversation with Anne Wojcicki and Richard Branson
When consumer genetics firm 23andMe announced Thursday that it will go public through a deal with the special purpose acquisition corporation VG...
-
STAT+: Google expands its health goals with new wellness features for Pixel phones
Google is taking a bite out of another piece of the health care pie. On Thursday, the tech giant announced plans to debut two wellness features...
-
Merck’s Kenneth Frazier, biopharma’s irreplaceable voice, to step down as CEO
Kenneth Frazier is stepping down as the CEO of Merck, leaving a giant hole in the fabric of the pharmaceutical industry. The decision, announced...
-
STAT+: Pharmalittle: Switzerland rejects AstraZeneca Covid-19 vaccine; McKinsey to pay $573 million over its role in opioid crisis
Good morning, everyone, and how are you today? We are doing just fine, thank you, now that the Pharmalot campus has settled down. Our short person...
-
McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers
The McKinsey & Co. consulting firm has reached a $573 million settlement with 47 states over its work advising Purdue Pharma and other drug...
-
23andMe to go public via Richard Branson’s SPAC
The genetics testing company 23andMe will enter the public markets via a special purpose acquisition corporation sponsored by Virgin Group founder...
-
Opinion: Truth and transparency after Covid-19: Mending the relationship between hospitals and the communities they serve
In April 2020, Víctor Santamaría was in an intensive care unit at Weill Cornell Medical Center in New York City with a breathing tube in...
-
Opinion: Mobilize family caregivers to speed the rollout of Covid-19 vaccines
Five years ago, I sat in a hospital lounge as a nurse laid out everything I as a caregiver would need to feed my husband intravenously: a bag of...
-
Thanks to physical distancing, masks, doctors see fewer cases of a polio-like condition in children
Many of the respiratory viruses that normally spike in the United States in the fall and winter are circulating at notably low levels right now...
-
Why some hospitals have to scramble for oxygen to treat Covid-19 patients
As Covid-19 cases began spiking last month, Mara Bryant and her hospital staff had to scramble to ensure enough oxygen was available. As the...
-
With a seductive number, AstraZeneca study fueled hopes that eclipsed its data
A new paper released this week suggested that a vaccine developed by AstraZeneca and Oxford University not only protected clinical trial...